GlassScriptPhysician profile
Cynthia Ann Madden
NPI 1336296417
$3,876.98
in general payments reported to CMS, 2019-2025
20 companies · $1,404 in 2025
The $1,404 reported for 2025 was more than what 97% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $558 · 2023: $962 · 2024: $953 · 2025: $1,404.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,319.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,319.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $722.15 | 2022-2025 | Airsupra, Breztri, Farxiga |
| Novo Nordisk INC | $617.19 | 2022-2025 | Wegovy |
| Gilead Sciences, INC. | $250.00 | 2023-2025 | Epclusa |
| Phathom Pharmaceuticals, INC. | $248.27 | 2024-2025 | Voquezna |
| Pfizer INC. | $239.80 | 2023-2025 | |
| Amgen INC. | $220.26 | 2025 | Krystexxa, Uplizna |
| Axsome Therapeutics, INC. | $183.57 | 2025 | Sunosi, Auvelity |
| Xeris Pharmaceuticals, INC. | $135.00 | 2025 | Gvoke Hypopen |
| Abbvie INC. | $125.00 | 2023 | |
| Genzyme Corporation | $125.00 | 2022 | |
| Verona Pharma, INC. | $125.00 | 2025 | Ohtuvayre |
| Otsuka America Pharmaceutical, INC. | $124.35 | 2024 | Rexulti |
| Neurelis, INC. | $118.59 | 2023 | Valtoco |
| Sanofi Pasteur INC. | $115.00 | 2022 | |
| Glaxosmithkline, LLC. | $107.75 | 2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $99.36 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $88.41 | 2022 | |
| Shield Therapeutics INC | $82.35 | 2023 | Accrufer |
| Bayer Healthcare Pharmaceuticals INC. | $77.48 | 2024 | |
| Sage Therapeutics, LLC | $72.45 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cynthia Madden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.